MAIA Biotechnology, Inc.
MAIA
$1.26
-$0.10-7.35%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 59.24% | -66.51% | -18.37% | -26.47% | -30.55% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 103.67% | -59.58% | 347.61% | 19.31% | 27.40% |
| Change in Net Operating Assets | -187.03% | 5,656.15% | -88.80% | 238.84% | 1,874.22% |
| Cash from Operations | -101.36% | 15.69% | 1.59% | -7.53% | -10.88% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 13.08% | 21.40% | -36.73% | 13.78% | 621.07% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.37% | 33.69% | 13.73% | -52.53% | -110.34% |
| Cash from Financing | 13.40% | 24.25% | -37.59% | 12.71% | 673.05% |
| Foreign Exchange rate Adjustments | -1,460.00% | -111.90% | 170.97% | 111.57% | -388.17% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -398.94% | 203.95% | -156.96% | 38.61% | 131.52% |